Co-expressed markers in the carcinoma/secretory NFTE group included known histological markers, such as PAX8 and STMN1, a proposed ancillary marker for detecting STIC lesions with a p53 null phenotype (Fig. 3G, Novak et al, 2015). Here, TP53 is linked to carcinoma.